Recent studies have characterized UBE2N as a crucial growth promoter of some human tumors, such as ovarian cancer and acute myeloid leukemia [6, 7], which indicates that UBE2N is an oncogene and potential therapeutic target for cancers. Here, UBE2N is linked to acute myeloid leukemia.